Briefing Chat: How 1,000 pairs of buried underpants helped measure soil health
Nature, Published online: 04 September 2026; doi:10.1038/d41586-026-02800-1 Nature staff discuss the winners of the 2026 Ig […]
Body parts used for ancient Egyptian artworks traced to surprising source
Nature, Published online: 04 September 2026; doi:10.1038/d41586-026-02739-3 Coffin decorations and wall paintings were made with tissue […]
Foreo Discount Codes and Deals: Up to 50% Off
Save on Foreo favorites, including LUNA cleansing brushes, BEAR microcurrent devices, and masks and accessories to level up your daily skincare routine at home.
Daily briefing: GLP-1 obesity drugs slow signs of ageing in mice
Nature, Published online: 03 September 2026; doi:10.1038/d41586-026-02781-1 Mice on GLP-1s also performed better on cognitive tasks […]
Nations expanding their research programmes impose sweeping penalties for malpractice
Nature, Published online: 03 September 2026; doi:10.1038/d41586-026-02517-1 India, Peru and Vietnam are rolling out policies that […]
[NEWS] CLINICAL TRIALS: Halt of Celebrex Study Threatens Drug’s Future, Other Trials
New research indicates Pfizer's COX-2 inhibitor Celebrex may cause increased risk of heart attacks and strokes, leading to the halting of some clinical trials involving the drug. Dozens of other COX-2 inhibitor trials are undergoing careful review. The scenario is strikingly similar to what happened this fall to Merck's COX-2 inhibitor Vioxx, which the Food and Drug Administration subsequently removed from the market.
Author: Jennifer Couzin